期刊文献+

单核细胞趋化蛋白-1抑制剂宾达利的合成及表征

Synthesis and characterization of bindarit, an inhibitor of monocyte chemoattractant protein-1
在线阅读 下载PDF
导出
摘要 为了解决目前宾达利(BIN)合成工艺难放大生产的问题,报道了一种高效制备BIN的方法。以吲唑-3-羧酸为起始原料,经酯化反应得到吲唑-3-羧酸甲酯(Ⅰ),该中间体与苄溴反应得到1-苄基吲唑-3-羧酸甲酯(Ⅱ),随后酯基进一步被硼氢化钠还原得到1-苄基吲唑-3-甲醇(Ⅲ)。最后中间体Ⅲ与氯仿、丙酮在碱性条件下反应得到目标产物BIN,通过^(1)HNMR、^(13)CNMR、HRMS和元素分析对BIN结构进行了表征。在n(Ⅲ)∶n(Na OH)∶n(CHCl;)=1∶10∶4,反应温度为55℃,反应时间为3 h的最佳反应条件下,BIN产率为65.0%。该法步骤简单,原料廉价易得,易于工业化生产。 In order to solve the problem that bindarit (BIN) synthesis process is difficult to industrially produce,an efficient method for the synthesis of BIN was reported.Firstly,methyl 1H-indazole-3-carboxylate(Ⅰ) was prepared by esterification reaction of 1H-indazole-3-carboxylic acid.Then,the intermediateⅠreacted with benzyl bromide to obtain methyl 1-benzyl-1H-indazole-3-carboxylate (Ⅱ).Subsequently,the ester group of compoundⅡwas further reduced by sodium borohydride and converted to (1-benzyl-1H-indazol-3-yl)methanol (Ⅲ).Finally,the reaction of the intermediateⅢwith chloroform and acetone in the presence of sodium hydroxide led to the target product BIN.The structure of BIN was confirmed by~1HNMR,^(13)CNMR,HRMS and elemental analysis.Under the optimum conditions of n(Ⅲ)∶n(NaOH)∶n(CHCl;)=1∶10∶4,reaction temperature of 55℃and reaction time of 3 h,the yield of BIN was 65.0%This method was characterized by simple and convenient operation,cheap and easily available raw materials and easy industrialized production.
作者 杨旭锋 闫玉兵 陈栋栋 YANG Xufeng;YAN Yubing;CHEN Dongdong(Department of Chemistry&Chemical Engineering,Lyuliang University,Lyuliang 033001,Shanxi,China)
出处 《精细化工》 EI CAS CSCD 北大核心 2022年第6期1223-1227,1276,共6页 Fine Chemicals
基金 山西省高等学校科技创新项目(2021L568,2019L0941) 吕梁市引进高层次科技人才重点研发项目(2019105)。
关键词 宾达利 吲唑-3-羧酸 单核细胞趋化蛋白-1抑制剂 酯基还原 硼氢化钠 医药原料 bindarit 1H-indazole-3-carboxylic acid monocyte chemoattractant protein-1 inhibitor ester group reduction sodium borohydride drug materials
作者简介 杨旭锋(1988-),男,博士,副教授,E-mail:yangxufeng2018@163.com。
  • 相关文献

参考文献2

二级参考文献16

  • 1Grassia G, Maddaluno M, Lalenti A, et al. The anti- inflammatory agent bindarit inhibits neointima forma- tion in both rats and hyperlipidaemic mice[J]. Cardio- vase Res ,2009,84:485 - 493.
  • 2Zoja C, Coma D, Benedetti G, et aL Bindarit retards renal disease and prolongs survival in murine lupus au- toimmune disease[ J ]. Kidey Int, 1998,53:726 - 734.
  • 3Torehiarolo C, Giuliano, Palaseiano F, et al. Process for the preparation of 1-benzyl-3-hydroxymethyl-lH-in dazole and its derivatives and required magnesium in- termediates[ P]. WO 2 011 015 502,2011.
  • 4Lohou E, Stiebing S, Rault S, et al. Direct access to 3-aminoindazoles by Buchwald-Hartwig C - N coupling reaction[ J ]. Synthesis,2011,16:2651 - 2663.
  • 5Iijima H, Iwakubo M, Takami A, et al. Design and synthesis of Rho kinase inhibitors( U ) [ J]. Bioorg Med Chem ,2007,15:350 - 364.
  • 6Henke B R, Aquino C J, Birkemo L S, et al. Optimi- zation of 3-( 1H-indazol-3-ylmethyl )-1, 5-benzodiaz-epines as potent, orally active CCK-A agonists [ J ]. J Med Chem, 1997,40:2706 - 2725.
  • 7Crestey F, Stiebing S, Rauh S, et al. A new and effi- cient synthesis of 2-azatryptophans [ J ]. Tetrahedron, 2006,62:7772 -7775.
  • 8Lokhande P D, Raheem A, Sabale S T, et al. An effi- cient synthesis of 1-H indazoles[ J]. Tetrahedron Lett, 2007,48:6890 - 6892.
  • 9Gaikwad D D, Abed S, Pawar R P. Molecular iodine as an ett3cient catalyst for the synthesis of indazole [ J ]. Int J ChemTech Res ,2009,1(3 ) :442 - 445.
  • 10Gibson F S, Bergmeier S C, Rapoport H. Selective removal of an N-BOC protecting group in the presence of a tert-butyl ester and other acid-sensitive groups [ J]. 1994,59:3216 - 3218.

共引文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部